Cargando…

Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria

BACKGROUND AND OBJECTIVE: Proteinuria assessment is key in investigating chronic kidney disease (CKD) but uncertainty exists regarding optimal methods. Albuminuria, reflecting glomerular damage, is usually measured, but non-albumin proteinuria (NAP), reflecting tubular damage, may be important. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraser, Simon D. S., Roderick, Paul J., McIntyre, Natasha J., Harris, Scott, McIntyre, Christopher, Fluck, Richard, Taal, Maarten W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035283/
https://www.ncbi.nlm.nih.gov/pubmed/24867154
http://dx.doi.org/10.1371/journal.pone.0098261
_version_ 1782318038544023552
author Fraser, Simon D. S.
Roderick, Paul J.
McIntyre, Natasha J.
Harris, Scott
McIntyre, Christopher
Fluck, Richard
Taal, Maarten W.
author_facet Fraser, Simon D. S.
Roderick, Paul J.
McIntyre, Natasha J.
Harris, Scott
McIntyre, Christopher
Fluck, Richard
Taal, Maarten W.
author_sort Fraser, Simon D. S.
collection PubMed
description BACKGROUND AND OBJECTIVE: Proteinuria assessment is key in investigating chronic kidney disease (CKD) but uncertainty exists regarding optimal methods. Albuminuria, reflecting glomerular damage, is usually measured, but non-albumin proteinuria (NAP), reflecting tubular damage, may be important. This study investigated the prevalence and associations of albuminuria and NAP, and the optimum number of urine specimens required. METHODS: 1,741 patients with CKD stage 3, recruited from primary care, underwent medical history, clinical assessment, blood sampling, and submitted three early morning urine samples for albumin to creatinine ratio (uACR) and protein to creatinine ratios (uPCR). Albuminuria was defined as uACR ≥3 mg/mmol in at least two of three samples. Isolated NAP was defined as uPCR ≥17 mg/mmol in two of three samples and uACR <3 mg/mmol in all three. Prevalence and associations of albuminuria and NAP, degree of agreement between single uACR and average of three uACRs, and urine albumin to protein ratio (uAPR = uACR/uPCR) were identified. RESULTS: Albuminuria prevalence was 16% and NAP 6%. Using a <1 mg/mmol threshold for uACR reduced NAP prevalence to 3.6%. Independent associations of albuminuria were: males (OR 3.06 (95% CI, 2.23–4.19)), diabetes (OR 2.14 (1.53–3.00)), lower estimated glomerular filtration rate ((OR 2.06 (1.48–2.85) 30–44 vs 45–59), and high sensitivity CRP ((OR 1.70 (1.25–2.32)). NAP was independently associated with females (OR 6.79 (3.48–13.26)), age (OR 1.62 (1.02–2.56) 80 s vs 70–79) and high sensitivity CRP ((OR 1.74 (1.14–2.66)). Of those with uPCR≥17 mg/mmol, 62% had uAPR<0.4. Sensitivity of single uACR was 95%, specificity 98%, PPV 90%. Bland Altman plot one vs average of three uACRs showed: mean difference 0.0064 mg/mmol (SD 4.69, limits of agreement −9.19 to +9.20, absolute mean difference 0.837). CONCLUSIONS: In CKD stage 3, albuminuria has associations distinct from those of isolated NAP (except for inflammatory markers). Single uACR categorised albuminuria but average of three performed better for quantification.
format Online
Article
Text
id pubmed-4035283
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40352832014-06-02 Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria Fraser, Simon D. S. Roderick, Paul J. McIntyre, Natasha J. Harris, Scott McIntyre, Christopher Fluck, Richard Taal, Maarten W. PLoS One Research Article BACKGROUND AND OBJECTIVE: Proteinuria assessment is key in investigating chronic kidney disease (CKD) but uncertainty exists regarding optimal methods. Albuminuria, reflecting glomerular damage, is usually measured, but non-albumin proteinuria (NAP), reflecting tubular damage, may be important. This study investigated the prevalence and associations of albuminuria and NAP, and the optimum number of urine specimens required. METHODS: 1,741 patients with CKD stage 3, recruited from primary care, underwent medical history, clinical assessment, blood sampling, and submitted three early morning urine samples for albumin to creatinine ratio (uACR) and protein to creatinine ratios (uPCR). Albuminuria was defined as uACR ≥3 mg/mmol in at least two of three samples. Isolated NAP was defined as uPCR ≥17 mg/mmol in two of three samples and uACR <3 mg/mmol in all three. Prevalence and associations of albuminuria and NAP, degree of agreement between single uACR and average of three uACRs, and urine albumin to protein ratio (uAPR = uACR/uPCR) were identified. RESULTS: Albuminuria prevalence was 16% and NAP 6%. Using a <1 mg/mmol threshold for uACR reduced NAP prevalence to 3.6%. Independent associations of albuminuria were: males (OR 3.06 (95% CI, 2.23–4.19)), diabetes (OR 2.14 (1.53–3.00)), lower estimated glomerular filtration rate ((OR 2.06 (1.48–2.85) 30–44 vs 45–59), and high sensitivity CRP ((OR 1.70 (1.25–2.32)). NAP was independently associated with females (OR 6.79 (3.48–13.26)), age (OR 1.62 (1.02–2.56) 80 s vs 70–79) and high sensitivity CRP ((OR 1.74 (1.14–2.66)). Of those with uPCR≥17 mg/mmol, 62% had uAPR<0.4. Sensitivity of single uACR was 95%, specificity 98%, PPV 90%. Bland Altman plot one vs average of three uACRs showed: mean difference 0.0064 mg/mmol (SD 4.69, limits of agreement −9.19 to +9.20, absolute mean difference 0.837). CONCLUSIONS: In CKD stage 3, albuminuria has associations distinct from those of isolated NAP (except for inflammatory markers). Single uACR categorised albuminuria but average of three performed better for quantification. Public Library of Science 2014-05-27 /pmc/articles/PMC4035283/ /pubmed/24867154 http://dx.doi.org/10.1371/journal.pone.0098261 Text en © 2014 Fraser et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fraser, Simon D. S.
Roderick, Paul J.
McIntyre, Natasha J.
Harris, Scott
McIntyre, Christopher
Fluck, Richard
Taal, Maarten W.
Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title_full Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title_fullStr Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title_full_unstemmed Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title_short Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
title_sort assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035283/
https://www.ncbi.nlm.nih.gov/pubmed/24867154
http://dx.doi.org/10.1371/journal.pone.0098261
work_keys_str_mv AT frasersimonds assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT roderickpaulj assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT mcintyrenatashaj assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT harrisscott assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT mcintyrechristopher assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT fluckrichard assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria
AT taalmaartenw assessmentofproteinuriainpatientswithchronickidneydiseasestage3albuminuriaandnonalbuminproteinuria